Kevin Madagan
FDA clarifies evidence and knowledge requirements in intended use final rule
Health Industry Washington Watch ·
FDA’s Section 804 Prescription Drug Importation Program and 801(d)(1)(B) Guidance
Life Sciences Legal Update ·
FDA revamps cybersecurity guidance for marketed medical devices
Technology Law Dispatch ·
FDA to implement OIG suggestions on IoT cybersecurity
Life Sciences Legal Update ·